DOPATREE
Preview
Open in TheBrain
DOPATREE
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
BLEEDING DISORDERS-ALL (COAGULAPATHY, HERITABLE BLEEDING DISORDERS, CLOTTING DISORDERS, HEMORRHAGE)
BLEEDING DISORDERS / TYPES / ACQUIRED
COAGULATION FACTOR DEFICIENCES-ALL
COAGULATION FACTOR DEFICIENCIES / TYPES
Parents
COAGULATION FACTOR DEFICIENCES-ALL
Children
FACTOR I DEFICIENCY (FIBRINOGEN DEFICIENCY)
FACTOR II DEFICIENCY (PROTHROMBIN DEFICIENCY)
FACTOR V DEFICIENCY (LABILE FACTOR DEFICIENCY, PROACCELERIN DEFICIENCY, OWREN’S DISEASE, PARAHEMOPHILIA)
FACTOR VII DEFICIENCY (FACTOR 7, F7, HYPOPROCONVERTINEMIA, LABILE FACTOR OR PROCONVERTIN, DEFICIENCY, ALEXANDER’S DISEASE)
FACTOR X DEFICIENCY (STUART FACTOR, STUART-PROWER FACTOR, F10, FX)
FACTOR XI DEFICIENCY (HEMOPHILIA C, PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY, PTA DEFICIENCY, ROSENTHAL SYNDROME, FXI, HAEMOPHILIA)
FACTOR XII DEFICIENCY (HAGEMAN FACTOR DEFICIENCY, F12 DEFICIENCY, HAF DEFICIENCY)
FACTOR XIII DEFICIENCY (FIBRIN STABILIZING FACTOR DEFICIENCY, F13, DEFICIENCY, LAKI-LORAND FACTOR)
INTRINSIC FACTOR DEFICIENCY (IFD, CONGENITAL PERNICIOUS ANEMIA DUE TO DEFECT OF INTRINSIC FACTOR)